Relationship Between Basic Laboratory Results and Fibrosis in Chronic Hepatitis B Patients
Journal Title: Viral Hepatitis Journal - Year 2019, Vol 25, Issue 2
Abstract
Objectives: Liver biopsy (LB) is an important cornerstone in decision to start treatment for chronic hepatitis B (HB). Viral load and liver function tests are performed to determine the most appropriate time. In this study, factors affecting liver fibrosis in hepatitis B e antigen (HBeAg) negative chronic hepatitis B patients were investigated. Materials and Methods: LB and the other laboratory results such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transpeptidase (GGT), and hepatitis B virus (HBV)-DNA were collected from patient files, retrospectively. According to study protocol, necroinflammatory scores ≤4 and fibrosis scores ≤1 were accepted as normal liver (NL), and the high value in one of these scores was accepted as chronic hepatitis (CH). Results: A total of 234 patient’s LBs included in the study. A total of 74 (31.6%) patients’ LB was evaluated as NL. In univariate analysis, age, gender, ALT, AST, GGT, AFP and HBV-DNA >100.000 IU/mL, and in multivariate analysis, age, AST level >29 U/L, and AFP level >2.5 ng/mL were the independent risk factors for CH. Conclusion: According to our results, age, AST and AFP predict CH. Doctors who follow up chronic hepatitis B patients should be carefully evaluate these parameters when giving LB decision.
Authors and Affiliations
Ertuğrul Güçlü, Aziz Öğütlü, Mustafa Kösem, Ünal Erkorkmaz, Oğuz Karabay
Keywords
Related Articles
- EP ID EP684554
- DOI 10.4274/vhd.galenos.2019.2019.0010
- Views 151
- Downloads 0
Diagnostic Performance of Non-invasive Fibrosis Indexes in Hepatitis B Related Fibrosis
Objectives: The aim of this study was to evaluate the diagnostic performance of non-invasive fibrosis markers [AST to platelet ratio (APRI), Fibrosis Index based on four factors (FIB-4) İndex, AST/platelet/GGT/Alpha-feto...
Influence of Sustained Virological Response on APRI in Chronic Hepatitis C: is APRI a Marker of Only the Stage of Fibrosis?
Objectives: Aspartate transaminase (AST) to platelet ratio index (APRI) is widely used to predict the stage of liver fibrosis in patients with chronic hepatit C virus (HCV) infection. In this study, we aimed to evaluate...
Non-hodgkin Lymphoma Developing After Discontinuation of Direct-acting Antiviral Treatment for Hepatitis C: A Case Report
Today, direct-acting antivirals (DAA) are the main treatment options for hepatitis C infection. However, whether malignancy risk is increased after DAA treatment is a matter of debate. Conflicting results have been repor...
Seroprevalence of HBsAg and Anti-HCV among HIV Positive Patients
Objectives: The study aimed to investigate the seroprevalence of hepatitis B surface antigen (HBsAg) and hepatitis C virus (anti- HCV) in human immunodeficiency virus (HIV) infected patients and to evaluate the results a...
Relationship between Viral Load and Hepatic Histopathology in Patients with Chronic Hepatitis B
Objectives: It is not always possible to determine a clear relationship between the DNA level of hepatitis B virus (HBV) and histology. In this study, we aimed to determine the relationship between HBV-DNA level and live...